NCT00002007
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +19 more
- Locations
-
- Natl Cancer Institute Bethesda, Maryland, United States
Clinical trial condition
Hematologic Diseases
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
15,364 public trials
2,842 recruiting studies
Hematologic Diseases trial results
NCT00002386
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood-Borne Infections, +22 more
- Locations
-
- USCF San Francisco, California, United States
- Georgetown U Med Ctr / Div of Hematology / Oncology Washington D.C., District of Columbia, United States
- Emory Univ Atlanta, Georgia, United States
- Riley Hosp for Children Indianapolis, Indiana, United States
- Conditions
- Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
- Locations
-
- Ortho Pharmaceutical Corp Raritan, New Jersey, United States
NCT00002276
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood-Borne Infections, +20 more
- Locations
-
- Hemophilia Ctr of Western PA / Univ of Pittsburgh Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants
NCT07708272
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- PKU Care Luzhong Hospital Zibo, Shandong, China
Active, Not Recruiting
A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome
NCT03899337
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- Royal Bournemouth Hospital Bournemouth, United Kingdom
- University Hospital of Wales Cardiff, United Kingdom
- Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
Active, Not Recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT04747613
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- City Of Hope National Med Center Duarte, California, United States
- City Of Hope Duarte, California, United States
- USC Norris Cancer Center Los Angeles, California, United States
- Univ Cali Irvine ALS Neuromuscular Orange, California, United States
Active, Not Recruiting
TriPRIL CAR T Cells in Multiple Myeloma
NCT05020444
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Active, Not Recruiting
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
- Locations
-
- Alaska Oncology and Hematology ( Site 0037) Anchorage, Alaska, United States
- Banner MD Anderson Cancer Center ( Site 0040) Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center - University Medical Center Phoenix-Medical Oncology ( Site 0036) Phoenix, Arizona, United States
- University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0008) Aurora, Colorado, United States
Active, Not Recruiting
Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
NCT04933539
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States